1. Home
  2. HTCR vs MBRX Comparison

HTCR vs MBRX Comparison

Compare HTCR & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

HOLD

Current Price

$2.65

Market Cap

4.4M

Sector

Technology

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$0.58

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTCR
MBRX
Founded
2009
2015
Country
Japan
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4M
4.3M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
HTCR
MBRX
Price
$2.65
$0.58
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$61.00
AVG Volume (30 Days)
27.8K
2.1M
Earning Date
05-14-2026
05-12-2026
Dividend Yield
87.84%
N/A
EPS Growth
414.29
N/A
EPS
N/A
N/A
Revenue
$30,407,229.00
N/A
Revenue This Year
$123.26
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
39.19
N/A
52 Week Low
$0.15
$0.16
52 Week High
$3.97
$7.98

Technical Indicators

Market Signals
Indicator
HTCR
MBRX
Relative Strength Index (RSI) 52.29 27.91
Support Level $2.43 $0.26
Resistance Level $2.91 $2.26
Average True Range (ATR) 0.20 0.07
MACD 0.02 0.07
Stochastic Oscillator 62.05 75.63

Price Performance

Historical Comparison
HTCR
MBRX

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

Share on Social Networks: